Admedus Ltd's COO Julian Chick talks to Proactive Investors on interim Herpes Simplex Virus Phase II clinical trial data
Admedus Ltd (ASX:AHZ) is a leading diversified healthcare group.
Quick facts: Admedus Ltd
Price: 8.3 AUD
Market Cap: $49.06 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Admedus Ltd named herein, including the promotion by the Company of Admedus Ltd in any Content on the Site, the Company receives from said...FOR OUR FULL DISCLAIMER CLICK HERE